Piflufolastat F-18 radioactive diagnostic imaging agent, per 1 millicurie dose

This code represents the diagnostic radiopharmaceutical piflufolastat F-18, a radioactive agent used in positron emission tomography (PET) imaging. It is specifically designed to target prostate-specific membrane antigen (PSMA) and is utilized for the detection and localization of prostate cancer.

Use this code when reporting the administration of piflufolastat F-18 for diagnostic PET scans. This typically occurs in patients with suspected or known prostate cancer, such as initial staging, biochemical recurrence, or to assess for metastatic disease. Documentation should clearly indicate the administration of piflufolastat F-18 and the dosage in millicuries.

• Ensure the dosage administered (1 millicurie) is clearly documented and matches the billed unit.
• This code represents the radiopharmaceutical itself, not the PET scan procedure; the PET scan will be billed separately.
• Verify payer-specific guidelines for coverage of PSMA PET imaging and associated radiopharmaceuticals.